Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hjc.2018.01.007 | DOI Listing |
EuroIntervention
November 2024
Department of Cardiac Surgery, Medical University Pisa, Pisa, Italy.
BMC Cardiovasc Disord
November 2024
Department of Internal Medicine I, Cardiology, Angiology, Intensive Medical Care, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany.
Background: In symptomatic high-risk patients with severe mitral valve regurgitation (MR), who are not eligible for surgery, Transcatheter edge-to-edge repair (TEER) or transcatheter mitral valve replacement (TMVR) may be an option, especially when surgical mitral valve repair by annuloplasty has been performed earlier. After TMVR, the appropriate anticoagulation regimen is still matter of debate.
Case Presentation: We here report on a 78-year-old frail lady with heart failure and atrial fibrillation who underwent surgical reconstruction of the mitral valve nine years ago.
Acta Cardiol
November 2024
Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
JACC Case Rep
May 2024
Department of Cardiology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
This clinical case describes a subacute presentation of decompensated heart failure secondary to an iatrogenic left ventricle-to-coronary sinus fistula after sequential mitral valve surgical procedures. Computed tomography was used to select an unconventional hybrid transapical access approach and facilitate successful closure using a vascular plug.
View Article and Find Full Text PDFCardiovasc Interv Ther
July 2024
Division of Cardiovascular Surgery, Toho University Ohashi Medical Center, 2-22-36 Ohashi, Meguro-Ku, Tokyo, 153-8515, Japan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!